Government in talks with various markets to accept Indian drug standards
Advertisement
New Delhi: India is nudging various semi-regulated markets like Myanmar and Kenya to accept its drug standards, instead of the US or British norms, a move aimed at helping many Indian drug makers to save cost on upgrading to international standards.
"We are in talks with various semi-regulated markets in ASEAN region, Africa and SAARC countries to accept Indian Pharmacopoeia instead of British Pharmacopoeia (BP)or the United States Pharmacopoeia (USP)", Pharmaceuticals Export Promotion Council of India (Pharmexcil) Director General PV Appaji told PTI.
In order to shore up support for the initiative, Pharmexcil has invited 10-15 drug regulatory heads from various countries to participate in the Indian Pharmaceutical Congress at Mysore next month, he added.
"Besides, we are already in talks with representatives from Ghana, Kenya and Myanmar regarding the issue", Appaji said.
"We are in talks with various semi-regulated markets in ASEAN region, Africa and SAARC countries to accept Indian Pharmacopoeia instead of British Pharmacopoeia (BP)or the United States Pharmacopoeia (USP)", Pharmaceuticals Export Promotion Council of India (Pharmexcil) Director General PV Appaji told PTI.
In order to shore up support for the initiative, Pharmexcil has invited 10-15 drug regulatory heads from various countries to participate in the Indian Pharmaceutical Congress at Mysore next month, he added.
"Besides, we are already in talks with representatives from Ghana, Kenya and Myanmar regarding the issue", Appaji said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.